echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > How can scientists help effectively fight cancer by stimulating the host's immune system?

    How can scientists help effectively fight cancer by stimulating the host's immune system?

    • Last Update: 2021-03-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    March 26, 2021 // - Cancer cells often evolve mechanisms to evade the host's immune defenses, and factors that prevent immune escape are often attractive targets for the development of new cancer therapies.


    Angewandte Chemie International Edition Scientists from the Max Planck Society of Germany and other institutions have developed a new cell-based detection system to identify immunomodulatory mediators through research.


    jpg">

    Our immune system is very successful in defending the host body against viruses and bacteria.


    A new inhibitor of IDO1—researchers are exploring

    A new inhibitor of IDO1—researchers are exploring

    Because of its cancer-driven effect, IDO1 has become the focus of scientists' medical research; however, so far, researchers have only achieved certain success in the search for IDO1 inhibitors, and are the first to be tested in clinical trials The IDO1 inhibitor epacadostat has almost no effect in clinical trials.


    In the process of drug discovery, experimental testing procedures, so-called detection methods, can often find new disease regulators in libraries of thousands of compounds; therefore, researchers use biochemical assays, if a certain species If the inhibitory effect is shown in the experiment, the biochemical reaction may be damaged; but this method has certain shortcomings and limitations, because the relevant experiment is carried out in the detection tube, not in the natural, natural, In a cellular environment.


    jpg">

    jpg">

    Image source: @MPI of Molecular Physiology

    New cell-based testing technology may be able to discover IDO1 inhibitors with different mechanisms of action

    New cell-based testing technology may be able to discover IDO1 inhibitors with different mechanisms of action

    In this study, researcher Herbert Waldmann and others have developed a cell-based test technology that can help discover new IDO1 inhibitors to overcome the limitations of cell-free detection.


    In this study, researcher Herbert Waldmann and others have developed a cell-based test technology that can help discover new IDO1 inhibitors to overcome the limitations of cell-free detection.


    Reference materials:

    Reference materials:

    [1] Elisabeth Hennes, Philipp Lampe, Lara Dotsch, et al.


    [1] Elisabeth Hennes, Philipp Lampe, Lara Dotsch, et al.


    【2】com/news/2021-03-immune-cancer.


    by Max Planck Society
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.